Cardea Bio
ExitedCardea Bio is the world’s only mass producer of biocompatible semiconductors, the BPU™ (Biosignal Processing Unit).
San Diego, United Stateswww.cardeabio.com ↗
Total raised
€0
€0
Funding rounds
0
Investors
0
distinct backers
Active since
—
Funding rounds
0 roundsNo funding rounds recorded.
Exit
Type
acquisition
Date
May 2023
Value
—
Acquiror
Paragraf (UK)
Related news
Similar companies
same sector or country- Arm€4.7BUK · Semiconductors
- NXP Semiconductors€1.0BNetherlands · Semiconductors
- Nearfield Instruments€524MNetherlands · Semiconductors
- Kandou€467MSwitzerland · Semiconductors
- Remote€440MUnited States · HRtech
- Axelera AI€381MNetherlands · Semiconductors